UPDATE: JPMorgan Upgrades Qiagen NV (QGEN) to Overweight

(update comment)

JPMorgan analyst Tycho Peterson upgraded Qiagen NV (NYSE: QGEN) from Underweight to Overweight with a price target of $40.00 (from $25.00).

The analyst comments "Barring a near-term takeout...we see potential for new management to reset the bar and pursue abundant opportunities for portfolio rationalization and cost reduction, and therefore we think the worst is in the rearview for QGEN."

For an analyst ratings summary and ratings history on Qiagen NV click here. For more ratings news on Qiagen NV click here.

Shares of Qiagen NV closed at $35.45 yesterday.

You May Also Be Interested In

• Energy Fuels (UUUU) PT Raised to $29.25 at H.C. Wainwright
• BTIG Upgrades Tidewater Inc (TDW) to Buy, 'Increasing Activity Set To Push Dayrates Higher in Key Basins'
• Aon Corp (AON) PT Lowered to $433 at Cantor Fitzgerald on Disappointing Upside from Deal